---
figid: PMC6109047__41598_2018_30692_Fig7_HTML
figlink: /pmc/articles/PMC6109047/figure/Fig7/
number: Figure 7
caption: Pictorial Abstract. A schematic summary showing how nuclosamide through the
  dysregulation of the Wnt/β-catenin signaling pathway, inhibits the stemness of OSCC
  cells via the downregulation of pluripotency transcription factors, suppress oral
  CSC -associated EMT and metastasis by upregulating vimentin and snail, while downregulating
  E-cadherin, as well as limit EMT-related extracellular matrix (ECM) remodeling by
  modulation of TIMP2, MMP2 and MMP9. Similarly, nuclosamide suppresses the cisplatin-induced
  oral CSC enrichment and enhances the sensitivity of the ALDH+ OSCC cells to cisplatin.
pmcid: PMC6109047
papertitle: The Antihelminthic Niclosamide Inhibits Cancer Stemness, Extracellular
  Matrix Remodeling, and Metastasis through Dysregulation of the Nuclear β-catenin/c-Myc
  axis in OSCC.
reftext: Lin-Hong Wang, et al. Sci Rep. 2018;8:12776.
pmc_ranked_result_index: '36183'
pathway_score: 0.9242276
filename: 41598_2018_30692_Fig7_HTML.jpg
figtitle: Pictorial Abstract
year: '2018'
organisms: Homo sapiens
ndex: 95604406-def1-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6109047__41598_2018_30692_Fig7_HTML.html
  '@type': Dataset
  description: Pictorial Abstract. A schematic summary showing how nuclosamide through
    the dysregulation of the Wnt/β-catenin signaling pathway, inhibits the stemness
    of OSCC cells via the downregulation of pluripotency transcription factors, suppress
    oral CSC -associated EMT and metastasis by upregulating vimentin and snail, while
    downregulating E-cadherin, as well as limit EMT-related extracellular matrix (ECM)
    remodeling by modulation of TIMP2, MMP2 and MMP9. Similarly, nuclosamide suppresses
    the cisplatin-induced oral CSC enrichment and enhances the sensitivity of the
    ALDH+ OSCC cells to cisplatin.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CTNNB1
  - TIMP2
  - CCND1
  - DVL2
  - SOX2
  - MMP2
  - CDH1
  - GSK3B
  - SNAI1
  - MMP9
  - NANOG
  - POU5F1
  - niclosamide
  - NANOG
  - cisplatin
genes:
- word: B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: TIMP2
  symbol: TIMP2
  source: hgnc_symbol
  hgnc_symbol: TIMP2
  entrez: '7077'
- word: cyclinD1
  symbol: Cyclin-D1
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: DVL2
  symbol: DVL2
  source: hgnc_symbol
  hgnc_symbol: DVL2
  entrez: '1856'
- word: SOX2
  symbol: SOX2
  source: hgnc_symbol
  hgnc_symbol: SOX2
  entrez: '6657'
- word: MMP2
  symbol: MMP2
  source: hgnc_symbol
  hgnc_symbol: MMP2
  entrez: '4313'
- word: E-cadherin
  symbol: CDH1
  source: hgnc_symbol
  hgnc_symbol: CDH1
  entrez: '999'
- word: GSK3B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: snail
  symbol: SNAIL
  source: hgnc_alias_symbol
  hgnc_symbol: SNAI1
  entrez: '6615'
- word: MMP9
  symbol: MMP9
  source: hgnc_symbol
  hgnc_symbol: MMP9
  entrez: '4318'
- word: NANOG
  symbol: NANOG
  source: hgnc_symbol
  hgnc_symbol: NANOG
  entrez: '79923'
- word: OCT4
  symbol: Oct4
  source: hgnc_alias_symbol
  hgnc_symbol: POU5F1
  entrez: '5460'
chemicals:
- word: niclosamide
  source: MESH
  identifier: D009534
- word: NANOG
  source: ''
  identifier: ''
- word: cisplatin
  source: MESH
  identifier: D002945
diseases: []
---
